Derm-Biome Pharmaceuticals, Inc. is a Vancouver based preclinical biopharmaceutical company focused on advancing safe and effective topical therapies for inflammatory skin diseases, precancerous skin conditions, and aging skin/longevity.
Founder: Gordon Eberwein
Company Details
- Employees
- 3
- Founded
- -
- Address
- 638 Beach Crescent, 1201,canada
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- derm-biome.com
- Keywords
- acne, eczema, rosacea, skin disease, aging skin, atopic dermatitis, skin cancer, actinic keratosis, anti-aging, inflammation.
- HQ
- Vancouver, British Columbia
Derm-Biome Pharmaceuticals, Inc Questions
Derm-Biome Pharmaceuticals, Inc's website is derm-biome.com
Derm-Biome Pharmaceuticals, Inc's LinkedIn profile is https://ca.linkedin.com/company/dermbiome
Derm-Biome Pharmaceuticals, Inc has
3 employees.
View email and phone details for 3
employees at Derm-Biome Pharmaceuticals, Inc.
Derm-Biome Pharmaceuticals, Inc's industry is
Hospitals and Health Care
Derm-Biome Pharmaceuticals, Inc's top competitors are
Racialized Students In Health Care,
L'oréal,
Pan-Biome Pharmaceuticals, Inc,
Royal Lepage,
Spectranotes,
Networks Of Centres Of Excellence,
Alto Pharmacy,
Corporate Directors International,
Legit Health Sciences,
Waterfall Scientific.
Derm-Biome Pharmaceuticals, Inc's categories are Hospitals and Health Care
Derm-Biome Pharmaceuticals, Inc's founding year is 2018
